Clinical updates, including trial initiations, enrollment status and data readouts and publications: Amylyx, Anavex, Aura, Biodexa, Curevo, George Medicines, Innovent, Kezar, Merck, Nektar, Neuvivo, Supernus, Theratechnologies.